Caxton Associates LP Sutro Biopharma, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.25 - $5.88 $32,380 - $44,799	-7,619 Reduced 26.3%	21,351 $99,000
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $216,267 - $407,915	-48,274 Reduced 62.5%	28,970 $133,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $184,584 - $253,848	35,703 Added 85.95%	77,244 $429,000
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $141,654 - $371,791	41,541 New	41,541 $216,000

137

61M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $99.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.